Attention: Website will be undergoing maintenance starting 8 am EDT on April 29, 2017 until 8 am EDT May 1, 2017. Online purchasing will not be available during this period. Items pending in shopping carts will be cleared after this maintenance period therefore users are advised to complete pending purchases prior to start of this maintenance period.

MATRICS™ (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery

Keith H. Nuechterlein, Ph.D.
Michael F. Green, Ph.D.

Technical Information

Normative data for the MCCB allows for age and gender correction; age, gender, and education correction; or no demographic correction. Both T-scores and percentiles are available.
Back to the top


For more information on the MCCB click here.
Back to the top

About the Authors

Keith H. Nuechterlein, Ph.D.
Keith H. Nuechterlein, Ph.D. is a Professor of Psychology at the University of California, Los Angeles; Director of the Aftercare Program, a research clinic for schizophrenic patients; UCLA Semel Institute of Neuroscience and Human Behavior; and also leads the UCLA Center for Neurocognition and Emotion in Schizophrenia. Dr. Nuechterlein specializes in neurocognitive processes in schizophrenia, especially as they relate to both the developmental course of the disorder and to functional outcome. Dr. Nuechterlein’s ongoing longitudinal study of the early course of schizophrenia, “Developmental Processes in Schizophrenic Disorders”, has closely examined the influence of specific neurocognitive vulnerability indicators on the early course of first-episode patients, with an emphasis on occupational and educational outcome. He holds a joint appointment in the Department of Psychiatry and Biobehavioral Sciences and the Department of Psychology (Clinical and Behavioral Neuroscience areas) at UCLA.

Michael Foster Green, Ph.D.
Michael Foster Green, Ph.D. is a Professor in the Department of Psychiatry and Biobehavioral Sciences at the Geffen School of Medicine at UCLA, and Director of the Treatment Unit of the VISN 22 MIRECC. Dr. Green obtained his B.A. in psychobiology at Oberlin College, his Ph.D. in neuropsychology at Cornell University, and did his postdoctoral training in neuropsychology at UCLA. His research activities are devoted to understanding the nature and implications of cognitive dysfunction in schizophrenia, including neurocognitive indicators of genetic vulnerability to schizophrenia and neural mechanisms of cognitive dysfunction. His laboratory explores the relationship between cognitive deficits in schizophrenia and activities of daily living, and the neurocognitive effects of antipsychotic and adjunctive medications. Dr. Green has authored over 120 journal articles and written two books: Schizophrenia from a Neurocognitive Perspective: Probing the Impenetrable Darkness, published in 1998, and Schizophrenia Revealed: From Neurons to Social Interactions, published in 2001. Dr. Green is currently president of the Society for Research in Psychopathology and is on the editorial boards of Schizophrenia Research, Schizophrenia Bulletin and Cognitive Neuropsychiatry.
Back to the top


Keith H. Nuechterlein, Ph.D. &
Michael F. Green, Ph.D.

Age Range 18 years and older

Administration Time 60 to 90 minutes  

Administration Type Professionally administered

Qualification Level C

  • Handscored
  • Software